Skip to content

Comparing Aerobic to Resistance Training in Recovery From Cancer

Comparing Aerobic to Resistance Training in Recovery From Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00237926
Enrollment
58
Registered
2005-10-13
Start date
2005-11-30
Completion date
Unknown
Last updated
2008-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasms

Keywords

Sleep, Fatigue, Exercise tolerance, Quality of life, Health status

Brief summary

The purpose of this study is to compare the health outcomes of a 12-week exercise program focused on aerobic training (using a treadmill) to a 12-week exercise program focused on resistance training (using Thera-Bands) in sedentary patients within 6 months of completing treatment for cancer.

Interventions

BEHAVIORALExercise

aerobic or resistance training

Sponsors

TriService Nursing Research Program
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* have a biopsy-proven cancer diagnosis * be within six months of having completed chemotherapy or radiation therapy for treatment for cancer as determined by the primary physician * be ambulatory but sedentary (i. e., has not followed an exercise regimen of a minimum of 3 times per week for at least 20 minutes each session over the previous six weeks) * have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 asymptomatic) or 1 (symptomatic, fully ambulatory) * be at least 18 years old * be able to read and speak English * have a medical statement from either the patient's primary care provider or the primary oncologist indicating that participation in the program is not medically contraindicated

Exclusion criteria

* following an exercise regimen a minimum of 3 times per week for at least 20 minutes each session within the previous 6 weeks * bone or joint destruction that could be aggravated with exercise * severe cognitive impairment identified by either the patient's medical care provider or by the study team * neuropathy-sensory common toxicity criteria (CTC) grade 3 (sensory loss or paresthesia interfering with activities of daily living) or grade 4 (permanent sensory loss that interferes with function) peripheral neuropathy

Design outcomes

Primary

MeasureTime frame
quality of life12-weeks

Secondary

MeasureTime frame
exercise tolerance12-weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026